Tag: Liver Disease: Misc.
Use of Living-Donor Liver Transplantation Low in U.S., U.K., Canada
One-, five-, 10-year patient survival was 92.6, 82.8, 70.0 percent in United States; 96.1, 89.9, and 82.2 percent in Canada
Prenatal Exposure to Endocrine-Disrupting Chemicals Linked to Liver Injury
Odds of liver injury in childhood increased with prenatal exposure to organochlorine pesticides, PBDEs, perfluoroalkyl substances, and metals
Sleep Tied to Metabolic Dysfunction-Associated Fatty Liver Disease
Highest risk for MAFLD was seen for those with disturbance in nighttime sleep and prolonged daytime napping
NAFLD Linked to Increased Risk for Dementia in Seniors
Greater risk for dementia conferred by comorbid nonalcoholic fatty liver disease and heart disease or stroke
113-Gene Signature May Predict Long-Term HCC Risk in NAFLD
Prognostic liver signature validated in cohorts of patients with NAFLD, with and without history of hepatocellular carcinoma
COVID-19 Tied to Progression of Chronic Liver Disease
About one in five patients with preexisting chronic liver disease develop progressive cholestasis after severe COVID-19
Risk for Existing, Incident T2D High in Children With NAFLD
Risk factors for incident T2D include female gender, BMI z-score, and more severe liver histology, including steatosis grade, fibrosis stage
Psoriasis Tied to Higher Risk for Nonalcoholic Fatty Liver Disease
Authors say this association may be relevant to psoriasis management with some antipsoriatic agents
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
DDW: Cardiovascular Disease More Common in Lean NAFLD Patients
Findings independent of other risk factors like age, sex, race, smoking status, diabetes, hypertension, and dyslipidemia
